Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Labianca

Showing results (71-80 of 174) with videos related to

Pageof 18
Sort By:
Mayo Clinic Proceedings|February 2, 2011
Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanomaMario Mandalà, Gian Lorenzo Imberti, Dario Piazzalunga, et al.
World Journal of Gastroenterology|December 29, 2007
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II studyGiuseppe Di Lorenzo, Antonio Rea, Chiara Carlomagno, et al.
Internal and Emergency Medicine|August 15, 2013
A prospective study on survival in cancer patients with and without venous thromboembolismGiancarlo Agnelli, Melina Verso, Mario Mandalà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Journal of the National Cancer Institute|May 20, 2004
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinomaRoberto Labianca, Roldano Fossati, Alberto Zaniboni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studiesFlorence Huguet, Thierry André, Pascal Hammel, et al.
Cancer|January 12, 2013
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapyFrank A Sinicrope, Nathan R Foster, Greg Yothers, et al.
Tumori|November 10, 2005
Cost of insurance policies for investigator-initiated cancer clinical trials in ItalyFrancesco Perrone, Maurizio Marangolo, Francesco Di Costanzo, et al.
Critical Reviews in Oncology/Hematology|February 9, 2010
Colon cancerRoberto Labianca, Giordano D Beretta, Basem Kildani, et al.
Tumori|June 29, 2002
"Misura" project: a retrospective survey on the use of 5fluorouracil in the treatment of colorectal cancer in 24 Italian clinical centersPaola Poletti, Graziella Pinotti, Gerardo Rosati, et al.
Pageof 18

Showing results (71-80 of 174) with videos related to

Sort By:
Pageof 18
Mayo Clinic Proceedings|February 2, 2011
Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanomaMario Mandalà, Gian Lorenzo Imberti, Dario Piazzalunga, et al.
World Journal of Gastroenterology|December 29, 2007
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II studyGiuseppe Di Lorenzo, Antonio Rea, Chiara Carlomagno, et al.
Internal and Emergency Medicine|August 15, 2013
A prospective study on survival in cancer patients with and without venous thromboembolismGiancarlo Agnelli, Melina Verso, Mario Mandalà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Journal of the National Cancer Institute|May 20, 2004
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinomaRoberto Labianca, Roldano Fossati, Alberto Zaniboni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studiesFlorence Huguet, Thierry André, Pascal Hammel, et al.
Cancer|January 12, 2013
Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapyFrank A Sinicrope, Nathan R Foster, Greg Yothers, et al.
Tumori|November 10, 2005
Cost of insurance policies for investigator-initiated cancer clinical trials in ItalyFrancesco Perrone, Maurizio Marangolo, Francesco Di Costanzo, et al.
Critical Reviews in Oncology/Hematology|February 9, 2010
Colon cancerRoberto Labianca, Giordano D Beretta, Basem Kildani, et al.
Tumori|June 29, 2002
"Misura" project: a retrospective survey on the use of 5fluorouracil in the treatment of colorectal cancer in 24 Italian clinical centersPaola Poletti, Graziella Pinotti, Gerardo Rosati, et al.
Pageof 18